Centrient
Sustainable leader in antibiotics, statins and anti-fungals
Centrient Pharmaceuticals is the global business-to-business leader in sustainable, enzymatic antibiotics, next-generation statins and anti-fungals. We produce and sell intermediates and active pharmaceutical ingredients (APIs), as well as our own tablets, capsules and other finished dosage forms (FDFs).
First established in 1869, our story has since been one of constant evolution and innovation. Today, we are a company 2,700-people strong with operations on four continents.
More than this, we are a pharmaceutical company with a clear mission: to improve lives by being at the centre of sustainable and accessible healthcare.
Our company has a common focus that unites each of us in our mission: across our global operations, we are committed to ensuring Quality, Reliability and Sustainability to customers, partners, patients and the world at large.
Moving forward, our vision is to be the leading, diversified and fully integrated partner to generics marketers.
Latest news
Planet B.io is a busy community, we are constantly developing and so are our collaborators, residents and members. To keep everyone updated we write articles and organise events. Take a look!
Unlocking the power of fungi: Myconeos' journey in innovation
Myconeos is revolutionizing the way we harness fungi for food and beyond. At its core, the company specializes in breeding new fungal strains using proprietary sexual crossing technology, enabling the creation of unique strains for cheese, plant-based foods, and even natural colorants.
Why DAB.bio chose to establish itself at Planet B.io
In Success Stories, we spotlight some of our favorite Residents who have made a lasting impact within the Planet B.io community. We kick off with DAB.bio, which develops and deploys cutting-edge fermentation technology.
Carapace Biopolymers | Biobased & biodegradable coating technology
Carapace Biopolymers, the first start-up to make use of Planet B.io’s flex office at Biotech Campus Delft, is working on innovative biobased and biodegradable coatings. By integrating biologicals they aim to boost seed germination and healthy plant growth. The company recently received the Biotech Booster Level 1 financing of EUR 200,000. Co-founders Suellen Espíndola and Marouschka Blahetek share their journey, goals, and vision.